This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novozymes A/s. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Carsten Ryttersgaard: Innovator in Glycoside Hydrolase Research
Introduction
Carsten Ryttersgaard is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of glycoside hydrolases, particularly through his innovative patents. With a total of 2 patents, Ryttersgaard's work is recognized for its impact on enzymatic research and applications.
Latest Patents
Ryttersgaard's latest patents focus on Galactanase variants. The first patent relates to variants of Glycoside Hydrolase family 53 galactanases, specifically variants derived from certain strains. The second patent also addresses variants of Glycoside Hydrolase family 53 galactanases, emphasizing the importance of these enzymes in various applications.
Career Highlights
Carsten Ryttersgaard is currently associated with Novozymes A/S, a leading company in the field of biotechnology. His work at Novozymes has allowed him to explore and develop innovative solutions in enzyme technology. His contributions have been instrumental in advancing the understanding of glycoside hydrolases.
Collaborations
Ryttersgaard has collaborated with notable colleagues, including Leonardo De Maria and Allan Svendsen. These collaborations have fostered a productive environment for research and innovation in enzyme development.
Conclusion
Carsten Ryttersgaard's contributions to the field of glycoside hydrolases through his patents and work at Novozymes A/S highlight his role as an influential inventor. His ongoing research continues to pave the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile